finanzen.net
27.03.2020 03:32

Coronavirus (COVID-19) Update: Daily Roundup

Werbung

SILVER SPRING, Md., March 26, 2020 /PRNewswire/ -- The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 pandemic:

  • The FDA issued guidance today on a Temporary Policy Regarding Nutrition Labeling of Certain Packaged Food During the COVID-19 Public Health Emergency. The FDA is issuing this guidance to provide restaurants and food manufacturers with flexibility regarding nutrition labeling so that they can sell certain packaged foods during the COVID-19 pandemic. For example, restaurants may have purchased ingredients that they can no longer use to prepare restaurant food and instead wish to sell to their customers.
  • The FDA posted questions and answers related to consumer use of hand sanitizer during the COVID-19 public health emergency. The FDA wants to make consumers aware of the steps the agency is taking to increase the supply of hand sanitizer during this public health emergency. The questions also discuss hand washing, expiration dates and other frequently asked questions by consumers on hand sanitizer.
  • Late yesterday, the FDA issued an immediately in effect guidance: Enforcement Policy for Face Masks and Respirators During the Coronavirus Disease-2019 (COVID-19) Public Health Emergency. The FDA believes the policy set forth in this guidance may help address urgent public health concerns by helping to expand the availability of general use face masks for the general public and particulate filtering facepiece respirators (including N95 respirators) for health care professionals.
  • The FDA took action today regarding 3D printing. The FDA entered into a Memorandum of Understanding (MOU) with the Department of Veterans Affairs and the National Institutes of Health, National Institute of Allergy and Infectious Diseases (NIH/NIAID), and is working with America Makes, the National Additive Manufacturing Innovation Institute, to facilitate connections between patients and healthcare providers, local manufacturers with capabilities, and designs for needed medical products. This MOU provides a framework for collaboration intended to facilitate regulatory and basic science innovation with 3D printing technologies to respond to COVID-19. Through this collaboration, the U.S. government and partners will help ensure that veterans and civilians have access to the most innovative medical solutions and technologies, including medical products that are manufactured close to the patient or at point-of-care. The FDA also issued FAQs on 3D Printing of Medical Devices During COVID-19 for entities who 3D print devices, accessories, components, and/or parts during the COVID-19 pandemic.
  • Diagnostics update to date: During the COVID-19 pandemic, the FDA has worked with more than 220 test developers who have said they will be submitting emergency use authorizations (EUA) requests to FDA for tests that detect the virus. To date, 17 emergency use authorizations have been issued for diagnostic tests, including the AvellinoCoV2 test, which is a real-time RT-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal and oropharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider. Additionally, FDA has been notified that more than 100 laboratories have begun testing under the policies set forth in our COVID-19 Policy for Diagnostic Tests for Coronavirus Disease-2019 during the Public Health Emergency Guidance. The FDA also continues to keep its COVID-19 Diagnostics FAQ up to date.

Additional Resources:

  • Coronavirus Disease 2019 (COVID-19)

Media Contact: Stephanie Caccomo, 301-348-1956 
Consumer Inquiries: 888-INFO-FDA

The FDA, an agency within the U.S. Department of Health and Human Services, protects the public health by assuring the safety, effectiveness, and security of human and veterinary drugs, vaccines and other biological products for human use, and medical devices. The agency also is responsible for the safety and security of our nation's food supply, cosmetics, dietary supplements, products that give off electronic radiation, and for regulating tobacco products.

U.S. Food and Drug Administration (FDA) logo (PRNewsfoto/FDA)

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/coronavirus-covid-19-update-daily-roundup-301030760.html

SOURCE U.S. Food and Drug Administration

Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

DAX legt zu -- Asiens Börsen mehrheitlich fest -- SAP kappt Prognose für 2020 -- Gerresheimer bestätigt Jahresausblick -- UBS teilt Dividende auf -- Starbucks, Airbus im Fokus

Diageo streicht Prognose. E.ON-Hauptversammlung soll virtuell stattfinden. Credit Suisse teilt Dividende in zwei Tranchen auf. Air France-KLM erwartet weitgehenden Geschäftsausfall bis Ende Mai. Ströer-Aktie: Coba streicht Kaufempfehlung. Corona-Krise trifft Takeaway im März nur vorübergehend. Ölpreise setzen Erholung fort.

Die 5 beliebtesten Top-Rankings

Die Länder mit den größten Goldreserven
Wer lagert das meiste Gold?
Welche Marken sind vorne mit dabei?
BrandZ-Ranking: Das sind die wertvollsten deutschen Marken
Das sind die besten Renten-Länder
In welchen Ländern lohnt es sich, zur Ruhe zu setzen?
Rohstoffe: Die Gewinner und Verlierer in Q1 2020
Welcher Rohstoff macht das Rennen?
MDAX: Die Gewinner und Verlierer in Q1 2020
Welche Aktie macht das Rennen?
mehr Top Rankings

Umfrage

Corona-Crash an den Börsen: Wird der DAX im April noch weiter fallen?

Online Brokerage über finanzen.net

finanzen.net Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von finanzen.net!

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Öl
Euro US-Dollar
Bitcoin
Goldpreis
Meistgesucht
Microsoft Corp.870747
Deutsche Bank AG514000
Wirecard AG747206
Scout24 AGA12DM8
Lufthansa AG823212
TeslaA1CX3T
Daimler AG710000
Shell (Royal Dutch Shell) (A)A0D94M
Airbus SE (ex EADS)938914
NEL ASAA0B733
Allianz840400
TUITUAG00
Amazon906866
Apple Inc.865985
Infineon AG623100